News
16h
Medpage Today on MSNSubcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New DataTORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...
StockStory.org on MSN1h
Earnings To Watch: Myriad Genetics (MYGN) Reports Q2 Results TomorrowGenetic testing company Myriad Genetics (NASDAQ:MYGN) will be announcing earnings results this Tuesday after market hours.
Measures intended to punish elite universities are inflicting collateral damage on the nation’s two-year colleges, which ...
StockStory.org on MSN7h
Earnings To Watch: Amgen (AMGN) Reports Q2 Results TomorrowBiotech company Amgen (NASDAQ:AMGN) will be reporting results this Tuesday after market hours. Here’s what to look for.
Marcus Evans announces the PharmaPack Summit 2025, an invitation-only event dedicated to the leaders defining the future of pharmaceutical packaging.
Of the companies that reported their results last week, 18 beat analysts’ earnings forecasts, while 3 missed. On the revenue ...
Sage Therapeutics, Inc. (Nasdaq: SAGE), today reported business highlights and financial results for the second quarter ended June 30, 2025.
Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results